The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

about

Soluble and Cell-Cell-Mediated Drivers of Proteasome Inhibitor Resistance in Multiple Myeloma.

P2860

Q55091606-D43C537D-D368-4172-910C-46AF27F62AE4

P2860

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

Item

http://www.wikidata.org/entity/Q47618731

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

@en

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

@nl

type

Item

label

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

@en

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

@nl

prefLabel

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

@en

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

@nl

P1476

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

@en

P2093

Katsuhiko Sakaguchi

http://www.w3.org/2001/XMLSchema#string

Kenji Mashimo

http://www.w3.org/2001/XMLSchema#string

Masanobu Tsubaki

http://www.w3.org/2001/XMLSchema#string

Motohiro Imano

http://www.w3.org/2001/XMLSchema#string

Sachi Hoshida

http://www.w3.org/2001/XMLSchema#string

Takao Satou

http://www.w3.org/2001/XMLSchema#string

Tatsuki Itoh

http://www.w3.org/2001/XMLSchema#string

Tomoya Takeda

http://www.w3.org/2001/XMLSchema#string

Yoshika Tomonari

http://www.w3.org/2001/XMLSchema#string

Yu-Ichi Koumoto

http://www.w3.org/2001/XMLSchema#string

P2860

Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes

International Myeloma Working Group consensus statement for the management, treatment, and supportive care of patients with myeloma not eligible for standard autologous stem-cell transplantation

Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors

Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER/PI3K/Akt/mTOR and IAP pathways

The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.

Over-expression of CKS1B activates both MEK/ERK and JAK/STAT3 signaling pathways and promotes myeloma cell drug-resistance

Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway.

Serum proinflammatory mediators at different periods of therapy in patients with multiple myeloma.

A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.

Survival and proliferation factors of normal and malignant plasma cells.

P304

4258-4271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCP.26245

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

233

http://www.w3.org/2001/XMLSchema#string

P50

Shozo Nishida

P577

2017-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29057477

http://www.w3.org/2001/XMLSchema#string

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

about

P2860

P2860

The MIP-1α autocrine loop contributes to decreased sensitivity to anticancer drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698